Limba
|
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.
Price | 16.249,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD. |